{
  "paper_id": "PMC6980246",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980246/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "Timing of first GOC discussion and EOL Care",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/010c39ab5148/nihms-1050857-f0001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/010c39ab5148/nihms-1050857-f0001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/010c39ab5148/nihms-1050857-f0001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/010c39ab5148/nihms-1050857-f0001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/010c39ab5148/nihms-1050857-f0001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC6980246/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/010c39ab5148/nihms-1050857-f0001.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Figure 3.",
      "caption": "Presence of hematologic oncologist at first GOC discussion and EOL\ncare",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/7be9f4a91dc3/nihms-1050857-f0003.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/7be9f4a91dc3/nihms-1050857-f0003.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/7be9f4a91dc3/nihms-1050857-f0003.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/7be9f4a91dc3/nihms-1050857-f0003.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/7be9f4a91dc3/nihms-1050857-f0003.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC6980246/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/7be9f4a91dc3/nihms-1050857-f0003.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.",
      "caption": "Location of first GOC discussion and EOL care",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/8f148b46e77d/nihms-1050857-f0002.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/8f148b46e77d/nihms-1050857-f0002.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/8f148b46e77d/nihms-1050857-f0002.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/8f148b46e77d/nihms-1050857-f0002.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/8f148b46e77d/nihms-1050857-f0002.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC6980246/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d75d/6980246/8f148b46e77d/nihms-1050857-f0002.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 3,
    "claims_count": 30,
    "images_downloaded": 3,
    "tables_filtered": 61
  }
}